Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 156

Sort by

Sort Order Select

Journal Articles

The dimorphism at the HLA-B leader and molecular HLA compatibility impact on haplo-HSCT: Experience of a single-center based on ptcy strategies

Blood (2025) 146 (Supplement 1): 2471.

https://doi.org/10.1182/blood-2025-2471

Published: 2025

Journal Articles

Impact of antibiotic use in early fever after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Maria José Llácer Ferrandis, Diana Casares-Aguiar, Ignacio Gómez-Centurión, Lucía Castilla, Rebeca Bailen, Paula Fernández-Caldas, Cristina Muñoz-Martínez, Santiago Sabell, Javier Anguita, Ramon Garcia-Sanz, Mi Kwon

Blood (2025) 146 (Supplement 1): 7712.

https://doi.org/10.1182/blood-2025-7712

Published: 2025

Journal Articles

Integrative omics analysis of TP53 in multiple myeloma patients

Cristina De Ramón Sánchez, Elizabeta A Rojas, Irena Misieweicz, Maria García-Alvarez, Myriam Cuadrado, Sara Cristobal, Ignacio J Cardona-Benavides, Isabel M Isidro, Maria Calasanz, Miguel Alcoceba, Ramon Garcia-Sanz, Laura Rosiñol Dachs, Joaquin Martinez-Lopez, Joan Batista Blade Creixenti, Juan-Jose Lahuerta Palacios, Jesus San-Miguel, María-Victoria Mateos, Luis Antonio Corchete Sanchez, Norma Gutiérrez

Blood (2025) 146 (Supplement 1): 2162.

https://doi.org/10.1182/blood-2025-2162

Published: 2025

Journal Articles

Prognostic impact of CAR-T cell expansion and PD1 expression in patients with DLBCL treated with axicabtagene ciloleucel

Diego Carbonell, Lucía Castilla, Julia Parra, Javier Bañón, David Sánchez-Pérez, Ana Pérez Corral, Rebeca Bailen, Leticia Gómez-Serrano, Pedro Rodríguez-Barquero, Mariana Bastos-Oreiro, Ignacio Gómez-Centurión, Paula Fernández-Caldas, Pablo Silva, Cristina Muñoz-Martínez, Gloria Ruano, Marian Galayo, Ramon Garcia-Sanz, Javier Anguita, Mi Kwon

Blood (2025) 146 (Supplement 1): 5503.

https://doi.org/10.1182/blood-2025-5503

Published: 2025

Journal Articles

Radiation-free therapy for the initial treatment of good prognosis early non-bulky HL, defined by a low metabolic tumor volume and a negative interim PET after 2 chemotherapy cycles. a phase II prospective rafting trial

Kateryna Filonenko, Marco Picardi, Michal Kurlapski, Livio Trentin, Eva Domingo Domenech, Caterina Patti, Ramon Garcia-Sanz, Javier Nuñez Cespedes, Javier Lopez Jimenez, Agnieszka Giza, Stephane Chauvie, Davide Rossi, Andrea Riccardo Filippi, Maria Pirosa, Marta Bednarek, Anna Sureda Balarí, Alessandro Rambaldi, Andrea Gallamini, Jan Maciej Zaucha

Blood (2025) 146 (Supplement 1): 8243.

https://doi.org/10.1182/blood-2025-8243

Published: 2025

Journal Articles

Efficacy and safety of CPX-351 in high-risk Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5231.

https://doi.org/10.1182/blood-2025-5231

Published: 2025

Journal Articles

Prognostic impact of specific IGHV rearrangements in younger untreated Mantle Cell Lymphoma patients is independent of p53 alterations and may be modified by ibrutinib-based regimens: Insights from the TRIANGLE trial within the MULTIPLY project

Blood (2025) 146 (Supplement 1): 5299.

https://doi.org/10.1182/blood-2025-5299

Published: 2025

Journal Articles

Prognostic value of minimal residual disease detection by circulating tumor DNA in Hodgkin lymphoma.

Blood (2025) 146 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2025-3541

Published: 2025

Journal Articles

Comprehensive DNA/RNA-based targeted sequencing for molecular karyotyping and clonality assessment in newly diagnosed multiple myeloma patients

Blood (2025) 146 (Supplement 1): 2562.

https://doi.org/10.1182/blood-2025-2562

Published: 2025

Journal Articles

Longitudinal biomarker dynamics for accurate risk prediction in 464 patients with asymptomatic IgM gammopathy: A spanish multicenter study

Blood (2025) 146 (Supplement 1): 2186.

https://doi.org/10.1182/blood-2025-2186

Published: 2025

Journal Articles

Hematologic neoplasms with germline DDX41 variants: Experience from nine spanish centers.

Miguel López-Esteban, Sara Torres-Esquius, Esperanza Tuset, Beatriz Gómez-Horsfield, Susana Vives, Jordi Viñas, Raquel De Paz Arias, Montserrat Arnan, Elena Bechtold, Lucía Pérez-Lamas, Carmen Talarn, Juan Restrepo, Yanira Florido, Ruth Stuckey, Ramon Garcia-Sanz, Ismael Buño, Maria Julia Montoro, Andres Jerez, Carolina Martinez-Laperche

Blood (2025) 146 (Supplement 1): 6744.

https://doi.org/10.1182/blood-2025-6744

Published: 2025

Journal Articles

Dexamethasone, Rituximab and Cyclophosphamide with Bortezomib is a rapidly acting and highly efficient first-line treatment in Waldenström's Macroglobulinemia: Final analysis of ECWM-1 trial of the European Consortium for Waldenström's Macroglobulinemia (ECWM)

Blood (2025) 146 (Supplement 1): 223.

https://doi.org/10.1182/blood-2025-223

Published: 2025

Journal Articles

ZUMA-25 preliminary analysis: A Phase 2 study of brexucabtagene autoleucel (brexu-cel) in patients (Pts) with relapsed/refractory (R/R) burkitt lymphoma (BL), substudy C

Blood (2025) 146 (Supplement 1): 569.

https://doi.org/10.1182/blood-2025-569

Published: 2025

Journal Articles

TP53 mutations in paired bone marrow and cell-free DNA samples of patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance prospectively enrolled in the FIL_biowm study of fondazione italiana linfomi

Blood (2025) 146 (Supplement 1): 5318.

https://doi.org/10.1182/blood-2025-5318

Published: 2025

Journal Articles

Comprehensive genomic profiling of diffuse large B cell lymphoma using targeted NGS: Insights into MYC, BCL2, and BCL6 rearrangements and beyond

Sara Fernánez de Córdoba, Mariana Bastos-Oreiro, Francisco Diaz Crespo, Ismael De La Iglesia San Sebastián, María Chicano, Juan Carlos Triviño, Marina Gomez-Llobell, Paula Fernandez-Caldas, Pablo Silva, Raquel Fernandez, Javier Menarguez, Ramon Garcia-Sanz, Ismael Buño, Carolina Martinez-Laperche

Blood (2025) 146 (Supplement 1): 5310.

https://doi.org/10.1182/blood-2025-5310

Published: 2025

Journal Articles

A Phase 2/3, multicenter, randomized, open-label study evaluating the efficacy and safety of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in frailer transplant-ineligible patients with newly diagnosed multiple myeloma

Blood (2025) 146 (Supplement 1): 2288.

https://doi.org/10.1182/blood-2025-2288

Published: 2025

Journal Articles

Results of abatacept addition to post transplant cyclophosphamide-based GVHD prophylaxys in allogeneic hematopoyetic stem cell transplantation

Paula Fernández-Caldas, María del Pilar Montero Anton, Rebeca Bailen, Ignacio Gómez-Centurión, Lucia Castilla, María José Llacer Ferrandis, Cristina Villanueva, José Luis Revuelta, Vicente Escudero, María Sanjurjo, Cristina Muñoz-Martínez, Santiago Sabell, Javier Anguita, Ramon Garcia-Sanz, Mi Kwon

Blood (2025) 146 (Supplement 1): 7778.

https://doi.org/10.1182/blood-2025-7778

Published: 2025

Journal Articles

The evaluation of the HLA-KIR interaction models may predict the NK alloreactivity in haplo-HSCT based on ptcy: Experience of a single spanish center

Francisco Javier Gil Etayo, Rodrigo Gil-Manso, JAIRO EDUARDO NIÑO RAMÍREZ, Marta Fonseca-Santos, JUAN LÓPEZ-PÉREZ, ISABEL JIMÉNEZ HERNAZ, ARIADNA VICENTE PARRA, PILAR TERRADILLOS SÁNCHEZ, NURIA CALZADA, DANIEL ARROYO-SÁNCHEZ, FRANCISCO BOIX, Almudena Navarro-Bailón, SARA MARCOS ASENSIO, Estefanía Pérez López, Ramon Garcia-Sanz, Fermin Sanchez-Guijo, Lucia Lopez Corral, AMALIA TEJEDA VELARDE

Blood (2025) 146 (Supplement 1): 4296.

https://doi.org/10.1182/blood-2025-4296

Published: 2025

Journal Articles

Outcomes of Allogeneic Transplantation with Clofarabine and Post-Transplant Cyclophosphamide-Based Conditioning in Patients with Very High-Risk Acute Myeloid Leukemia

Lucia Castilla Garcia, Rebeca Bailen, Ignacio Alberto Gomez Centurion Luna, Paula Fernández-Caldas, Pablo Silva De Tena, Carolina Martinez-Laperche, Javier Anguita, Ramon Garcia-Sanz, Mi Kwon

Blood (2024) 144 (Supplement 1): 4889.

https://doi.org/10.1182/blood-2024-210237

Published: 2024

Journal Articles

Integration of Geriatric Assessment and Genetic Profile Facilitates Personalized Treatment Selection and Follow-up in Old Patients with Newly Diagnosed Acute Myeloid Leukemia

Pilar Lancho Lavilla, Miguel Lopez-Esteban, Javier Ortiz-Alonso, Gracia Fajardo-Tórtola, Patricia Font Lopez, Marina Gomez Llobell, Jose Antonio Serra Resach, Ana Perez-Corral, Isabel Regalado Artamendi, Mónica Ballesteros Andrés, Carolina Martinez-Laperche, Gloria Figaredo Garcia-Mina, Raquel Fernández González, Carlos Jiménez, Diego Conde Royo, Cristina Pascual Izquierdo, María Teresa Vidán, Ramon García-Sanz, Gabriela Rodriguez Macias

Blood (2024) 144 (Supplement 1): 5050.

https://doi.org/10.1182/blood-2024-203872

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The dimorphism at the HLA-B leader and molecular HLA compatibility impact on haplo-HSCT: Experience of a single-center based on ptcy strategies

Impact of antibiotic use in early fever after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Integrative omics analysis of TP53 in multiple myeloma patients

Prognostic impact of CAR-T cell expansion and PD1 expression in patients with DLBCL treated with axicabtagene ciloleucel

Radiation-free therapy for the initial treatment of good prognosis early non-bulky HL, defined by a low metabolic tumor volume and a negative interim PET after 2 chemotherapy cycles. a phase II prospective rafting trial

Efficacy and safety of CPX-351 in high-risk Acute Myeloid Leukemia

Prognostic impact of specific IGHV rearrangements in younger untreated Mantle Cell Lymphoma patients is independent of p53 alterations and may be modified by ibrutinib-based regimens: Insights from the TRIANGLE trial within the MULTIPLY project

Prognostic value of minimal residual disease detection by circulating tumor DNA in Hodgkin lymphoma.

Comprehensive DNA/RNA-based targeted sequencing for molecular karyotyping and clonality assessment in newly diagnosed multiple myeloma patients

Longitudinal biomarker dynamics for accurate risk prediction in 464 patients with asymptomatic IgM gammopathy: A spanish multicenter study

Hematologic neoplasms with germline DDX41 variants: Experience from nine spanish centers.

Dexamethasone, Rituximab and Cyclophosphamide with Bortezomib is a rapidly acting and highly efficient first-line treatment in Waldenström's Macroglobulinemia: Final analysis of ECWM-1 trial of the European Consortium for Waldenström's Macroglobulinemia (ECWM)

ZUMA-25 preliminary analysis: A Phase 2 study of brexucabtagene autoleucel (brexu-cel) in patients (Pts) with relapsed/refractory (R/R) burkitt lymphoma (BL), substudy C

TP53 mutations in paired bone marrow and cell-free DNA samples of patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance prospectively enrolled in the FIL_biowm study of fondazione italiana linfomi

Comprehensive genomic profiling of diffuse large B cell lymphoma using targeted NGS: Insights into MYC, BCL2, and BCL6 rearrangements and beyond

A Phase 2/3, multicenter, randomized, open-label study evaluating the efficacy and safety of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in frailer transplant-ineligible patients with newly diagnosed multiple myeloma

Results of abatacept addition to post transplant cyclophosphamide-based GVHD prophylaxys in allogeneic hematopoyetic stem cell transplantation

The evaluation of the HLA-KIR interaction models may predict the NK alloreactivity in haplo-HSCT based on ptcy: Experience of a single spanish center

Outcomes of Allogeneic Transplantation with Clofarabine and Post-Transplant Cyclophosphamide-Based Conditioning in Patients with Very High-Risk Acute Myeloid Leukemia

Integration of Geriatric Assessment and Genetic Profile Facilitates Personalized Treatment Selection and Follow-up in Old Patients with Newly Diagnosed Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only